2014
-
. ., 68 ,
.. 174170/106-100 mmHg 10,
.
40
(+):
51
: tabs O
= 178/100 mmHg
(2
, min)
= 170/96 mmHg
= 72/min
:
174-170/106-100 mmHg (3-4 )
87 kg 1,69 m 30,5 Kg/m2
= 108 cm
: S1, S2 ,
.
: .. ..
:
: --, ..
;
1. 6 ;
2. ;
3.
;
4.
:
,
,
.
24 (BPM)
,
24-
,
.
.
.
,
.
24 (PM)
24 -
172
98
123
68
07:00-23:00
178
100
123
69
23:00-07:00
170
96
120
66
Ht: 45%
. A
WBC: 8520
PLT: 268x 103
. = 1025
= (-)
= (-)
(> 300mg/g)
,
Alb/Cr.
:
-
.
-
CVD.
lb/Cr = 49 mg/g
(.. 3,4 - 34 mg/g)
24
U/S NOK:
(
): 110 mg/dl
: 46 mg/dl
: 1,2 mg/dl
eGFR: 70 ml/min/1,73m2
: 3,1 mg/dl
: 4,4 mEq/l
: 142 mEq/l
: 268 mg/dl
LDL: 146 mg/dl
HDL: 37 mg/dl
: 214 mg/dl
HbA1c: 5,9 %
:
. : 116 mg/dl
. 2 : 175 mg/dl
ECHO
...
LA: 39mm
LV: ,
F: 55%
AVR: ,
:
:
1.
(IMT > 0,9)
2. - (ABI) < 0,9
3. -
(PWV > 12 m/sec)
,
Grade 2 A :
-
( ),
- :
- ,
- ,
-
.
1)
;
2)
;
3)
,
;
1. :
2. vs.
5
Wald et al, Am J Med 2009;122:290-300
:
Reduced discontinuation of antihypertensive treatment by
two-drug combination as first step. Evidence from daily
life practice. Corrao G, Parodi A, Zambon A, Heiman F, Filippi
A, Cricelli C, Merlino L, Mancia G.
J Hypertens 2010;28:15841590.
3.
:
abl. 10mg
abl. 5mg
20%
n=11,516
ASCOT - CV events
Prevention of cardiovascular events with an antihypertensive
regimen of amlodipine adding perindopril as required vs. atenolol
adding bendroflumethiazide as required in the Anglo-Scandinavian
Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOTBPLA) a multicentre randomised controlled trial.
/
/ 16% (P <
0,001)
:
abl. 10mg,
abl. 5mg
, : 160 154/92-98
mmHg.
:
abl. 20 mg,
abl. 10mg
6
.
PM
24 -
144
86
105
70
07:00-23:00
148
88
108
72
23:00-07:00
140
82
101
68
;;;;;
-
- (
)
-
-